Effects of vascular endothelial growth factor released from cultured dermal substitute on proliferation of vascular endothelial cells in vitro

Journal of Artificial Organs

Volumn 6, Issue 4, 2003, Pages 267-272

  Kubo, Kentaro ^a   Kuroyanagi, Yoshimitsu ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Cultured dermal substitute; Fibroblasts; Vascular endothelial cells; Vascular endothelial growth factor (VEGF)

Indexed keywords

VASCULOTROPIN;

ARTICLE; ARTIFICIAL SKIN; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CRYOPRESERVATION; CULTURE MEDIUM; CULTURED DERMAL SUBSTITUTE; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; THAWING; VASCULAR ENDOTHELIUM;

CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; CRYOPRESERVATION; CYTOKINES; ENDOTHELIUM, VASCULAR; HUMANS; SENSITIVITY AND SPECIFICITY; SKIN, ARTIFICIAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0346788753     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10047-003-0239-3     Document Type: Article

References (29)

1. Green H, Kehinde O, Thomas J. Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci USA 1979;76:5665-5668
2. Bell E, Ehrlich HP, Sher S, Merrill C, Sarber R, Hull B, Nakatsuji T, Church D. Development and use of a living skin equivalent. Plast Reconstr Surg 1981;67:386-392
3. Cooper ML, Hansbrough JF, Spielvogel RL, Cohen R, Bartel RI, Naughton G. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials 1991;12:243-248
4. Hansbrough JF, Morgan J, Greenleaf G. Development of a temporary living skin replacement composed of human neonatal fibroblasts cultured in Biobrane, a synthetic dressing material. Surgery 1994;115:633-644
5. O'Connor NE, Muliken JG, Banks-Schlegel S, Kehinde O, Green H. Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1982;1:75-78
6. Gallico GG, O'Connor NE, Compton CC, Kehinde O, Green H. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 1984;311:448-451
7. Hansbrough JF, Dore C, Hansbrough WB. Clinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin grafts on excised burn wounds. J Burn Care Rehabil 1992;13:519-529
8. Gentzkow GD, Iwasaki SD, Hershon KS, Mengel M, Prendergast JJ, Ricotta JJ, Steed DP, Lipkin S. Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 1996;19:350-354
9. Hansbrough JF, Mozingo DW, Kealey GP, Davis M, Gidner A, Gentzkow GD. Clinical trials of a biosynthetic temporary skin replacement, Dermagraft-Transitional Coverage, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J Burn Care Rehabil 1997;18:43-51
10. Parenteau N. Skin: the first tissue-engineered products. The organogenesis story. Sci Am April 1999:59-60
11. Yamada N, Shioya N, Kuroyanagi Y. Evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix as a wound dressing. Scand J Plast Reconstr Surg 1995;29:211-219
12. Tanaka M, Nakakita N, Kuroyanagi Y. Allogeneic cultured dermal substitute composed of spongy collagen containing fibroblasts: evaluation in animal test. J Biomater Sci Polymer Edn 1999;10:433-453
13. Yamashita R, Kuroyanagi Y, Nakakita N, Uchinuma E, Shioya N. Allogeneic cultured dermal substitute composed of spongy collagen containing fibroblasts: preliminary clinical trials. Wounds 1999;11:34-44
14. Yamada N, Uchinuma E, Kuroyanagi Y. Clinical evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix. Scand J Plast Reconstr Surg 1999;33:147-154
15. Kuroyanagi Y, Yamada N, Yamashita R, Uchinuma E. Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts. Artif Organs 2001;25:180-186
16. Clark RAF. Overview and general consideration of wound repair. In: Clark RAF, Henson PM (eds) The molecular and cellular biology of wound repair. New York: Plenum, 1988;3-33
17. Postlethwaite AE, Seyer JM, Kang AH. Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc Natl Acad Sci USA 1978;75:871-875
18. Kubo K, Kuroyanagi Y. Development of cultured dermal substitute composed of hyaluronic acid and collagen combined with fibroblasts; fundamental evaluation. J Biomater Sci Polymer Edn, 2003;64:625-641
19. Kuroyanagi Y, Kubo K, Matsui H, Kagawa S, Mori S, Kim H, Mabuchi Y. Manufacturing and banking system for allogeneic cultured dermal substitute (Regenerative Medical Millennium Project of the Ministry of Health, Labor and Welfare). Jpn J Burn Injuries 2003;29:28-38
20. Kubo K, Kuroyanagi Y. Development of cultured dermal substitute composed of hyaluronic acid and collagen combined with fibroblasts; cryopreservation. Artif Organs (in press)
21. Oka H, Fujitsu M, Suenobu K, Moriguchi T, Kubo K, Matsui H, Kagawa S, Kuroyanagi Y. Clinical trials with allogeneic cultured dermal substitutes (CDS) for the treatment of burns and skin ulcers (Regenerative Medical Millennium Project of the Ministry of Health, Labor and Welfare). Jpn J Burn Inj 2002;28:333-342
22. Harima N, Ansai S, Wako M, Manabe M, Kubo K, Matsui H, Kagawa S, Kuroyanagi Y. Clinical trials of allogeneic cultured dermal substitutes (CDS) for the treatment of burns and skin ulcers (Regenerative Medical Millennium Project of the Ministry of Health, Labor and Welfare). Jpn J Dermatol 2003;113:253-264
23. Ausprunk DH, Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 1977;14:53-65
24. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro LA. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998;152:1445-1452
25. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851-858
26. Kumar R, Yoneda J, Fidler IJ. Regulation of distinct steps of angiogenesis by different angiogenic molecules. Int J Oncol 1998;12:749-757
27. Howdieshell TR, Callaway D, Webb WL, Gaines MD, Procter CD, Sathyanarayana, Pollock JS, Brock TL, McNeil PL. Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation. J Surg Res 2001;96:173-182
28. Kubo K, Kuroyanagi Y. Spongy matrix of hyaluronic acid and collagen for cultured dermal substitute: evaluation in animal test. J Artif Organs 2003;6:64-70
29. Kubo K, Kuroyanagi Y. Characterization of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and collagen combined with fibroblasts. J Artif Organs, 2003;6:138-144